Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Abstract Background In 2018, intravenous abatacept was approved for the treatment of refractory polyarticular-course juvenile idiopathic arthritis (JIA) in Japan. However, reports describing the effectiveness and safety of abatacept in clinical practice in Japanese patients with refractory polyartic...

Full description

Bibliographic Details
Main Authors: Tomo Nozawa, Naomi Iwata, Toru Igarashi, Ichiro Kobayashi, Shoji Ota, Takako Yamada, Etsuya Bando, Katsuyoshi Habiro, Syuji Takei
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Polyarticular-course juvenile idiopathic arthritis
Abatacept
Postmarketing surveillance study
Juvenile Arthritis Disease Activity Score 27
Standard deviation score
Growth retardation
Online Access:https://doi.org/10.1186/s12969-025-01069-4

Internet

https://doi.org/10.1186/s12969-025-01069-4

Similar Items